Cargando…
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic
Autores principales: | Russo, Alessandro, Venditti, Mario, Ceccarelli, Giancarlo, Mastroianni, Claudio Maria, d’Ettorre, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880514/ https://www.ncbi.nlm.nih.gov/pubmed/33580413 http://dx.doi.org/10.1007/s11739-021-02659-2 |
Ejemplares similares
-
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
por: Violi, Francesco, et al.
Publicado: (2021) -
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients—Results from a Retrospective Observational Study in Intensive Care Units
por: Ceccarelli, Giancarlo, et al.
Publicado: (2023) -
Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels
por: So, Wonhee, et al.
Publicado: (2022) -
Is previous influenza-like illness a potential Trojan horse for COVID-19?
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020) -
Probiotics and COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)